Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Active not recruiting 27Recruiting 13Completed 2Not yet recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2Plasma cell 1Other hematologic neoplasm 1

Conditions

Lymphoma, Mantle-Cell 2Waldenstrom Macroglobulinemia 1Multiple Myeloma 1Lymphoma, Follicular 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, Hairy Cell 1Hodgkin Disease 1Burkitt Lymphoma 1

Interventions

pembrolizumab 67Cyclophosphamide 45Cisplatin 45Nivolumab 39Paclitaxel 35Carboplatin 31Radiotherapy 30Gemcitabine 28Docetaxel 27Dexamethasone 23atezolizumab 22Bevacizumab 20Doxorubicin 19Vincristine 17Magnetic Resonance Spectroscopy 17Lenalidomide 17fludarabine 16Radiosurgery 16Fluorouracil 16Etoposide 16Blood Specimen Collection 16Rituximab 15Radiation 15Letrozole 15Irinotecan 15Ipilimumab 15palbociclib 14Leucovorin 14Cytarabine 14Surveys and Questionnaires 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × acalabrutinib × 90 days × Clear all
NCT02362035 2026-05-13

KEYNOTE145

Acerta Pharma BV

Phase 1/2 Completed
161 enrolled 29 charts
LymphoidOther hematologic neoplasmPlasma cell

Burkitt Lymphoma, Hodgkin Disease, Leukemia, Hairy Cell, Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Mantle-Cell

NCT03623373 2026-04-21

Acalabrutinib With Bendamustine / Rituximab Followed by Cytarabine / Rituximab for Untreated Mantle Cell Lymphoma

Washington University School of Medicine

Phase 2 Completed
13 enrolled 13 charts
Lymphoid

Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡